SHAREHOLDER NOTICE: Kaskela Law LLC Announces Shareholder Investigation of Amicus Therapeutics, Inc. (NASDAQ: FOLD) and Encourages Long-Term FOLD Investors to Contact the Firm

Core Viewpoint - Kaskela Law LLC is investigating Amicus Therapeutics, Inc. on behalf of its shareholders due to a significant decline in stock value and potential violations of securities laws or breaches of fiduciary duties by the company's officers and directors [1][2]. Group 1: Stock Performance - Year to date, shares of Amicus' stock have declined over 32% in value, trading at a current price of less than $7.00 per share [2]. Group 2: Legal Investigation - The investigation aims to determine if Amicus and/or its officers and directors violated securities laws or breached fiduciary duties in connection with recent corporate actions [2]. - Shareholders are encouraged to contact Kaskela Law LLC for additional information regarding the investigation and their legal rights [3].